CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY - Get Free Report) saw a large growth in short interest in the month of August. As of August 31st, there was short interest totaling 1,900 shares, a growth of 533.3% from the August 15th total of 300 shares. Based on an average trading volume of 6,100 shares, the short-interest ratio is presently 0.3 days. Approximately 0.0% of the company's stock are sold short. Approximately 0.0% of the company's stock are sold short. Based on an average trading volume of 6,100 shares, the short-interest ratio is presently 0.3 days.
CochLear Stock Performance
Shares of CHEOY stock traded up $0.06 on Thursday, hitting $99.58. The stock had a trading volume of 3,130 shares, compared to its average volume of 10,888. The business has a 50 day moving average of $99.59 and a 200 day moving average of $90.83. CochLear has a 12-month low of $74.76 and a 12-month high of $105.60.
Analysts Set New Price Targets
CHEOY has been the topic of several research reports. UBS Group upgraded shares of CochLear from a "hold" rating to a "strong-buy" rating in a report on Wednesday, June 18th. Zacks Research upgraded shares of CochLear to a "hold" rating in a report on Monday, August 11th. One analyst has rated the stock with a Strong Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy".
Read Our Latest Report on CHEOY
About CochLear
(
Get Free Report)
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CochLear, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CochLear wasn't on the list.
While CochLear currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.